DVAX
Dynavax Technologies Corporation
NASDAQ: DVAX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$15.50
+0.00% today
Updated 2026-02-11
Market cap
$1.82B
P/E ratio
—
P/S ratio
5.51x
EPS (TTM)
$-0.37
Dividend yield
—
52W range
$9 – $16
Volume
3.5M
WallStSmart proprietary scores
45
out of 100
Grade: C
Sell
Investment rating
3.3
Growth
D5.8
Quality
C+3.0
Profitability
D5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
1.0
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →194 stocks currently score above 75
Price targets
Analyst target
$16.00
+3.23%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $32.59M — positive
Risks
- Altman Z 0.98 — distress zone
- Thin margins at -0.13%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $439.44M | $722.68M | $232.28M | $277.25M | $330.51M |
| Net income | $76.71M | $293.16M | $-6.39M | $27.31M | $26.93M |
| EPS | — | — | — | — | $-0.37 |
| Free cash flow | $326.05M | $55.58M | $96.46M | $60.16M | $32.59M |
| Profit margin | 17.46% | 40.56% | -2.75% | 9.85% | -0.13% |
Peer comparison
Smart narrative
Dynavax Technologies Corporation trades at $15.50. Our Smart Value Score of 45/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 0.98, it sits in the distress. TTM revenue stands at $330.51M. with profit margins at -0.13%.
Frequently asked questions
What is Dynavax Technologies Corporation's stock price?
Dynavax Technologies Corporation (DVAX) trades at $15.50.
Is Dynavax Technologies Corporation overvalued?
Smart Value Score 45/100 (Grade C, Sell).
What is the price target of Dynavax Technologies Corporation (DVAX)?
The analyst target price is $16.00, representing +3.2% upside from the current price of $15.50.
What is Dynavax Technologies Corporation's revenue?
TTM revenue is $330.51M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
0.98 — distress.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio5.51x
ROE-0.07%
Beta0.93
50D MA$13.85
200D MA$11.24
Shares out0.11B
Float0.10B
Short ratio—
Avg volume3.5M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—